Jenny Sundqvist
Chief Executive Officer bij INDEX PHARMACEUTICALS HOLDING AB
Profiel
Jenny Sundqvist is currently the Chief Executive Officer at InDex Pharmaceuticals Holding AB.
Previously, she worked as the Chief Commercial Officer at Isofol Medical AB.
From 2017 to 2021, she held the position of Head-Oncology Portfolio at AstraZeneca PLC.
Ms. Sundqvist completed her undergraduate degree at Louisiana State University and obtained an MBA from McCombs School of Business.
Actieve functies van Jenny Sundqvist
Bedrijven | Functie | Begin |
---|---|---|
INDEX PHARMACEUTICALS HOLDING AB | Chief Executive Officer | 01-01-2023 |
Eerdere bekende functies van Jenny Sundqvist
Bedrijven | Functie | Einde |
---|---|---|
ASTRAZENECA PLC | Corporate Officer/Principal | 01-04-2021 |
ISOFOL MEDICAL AB | Corporate Officer/Principal | - |
Opleiding van Jenny Sundqvist
Louisiana State University | Undergraduate Degree |
McCombs School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
ASTRAZENECA PLC | Health Technology |
INDEX PHARMACEUTICALS HOLDING AB | Health Technology |
ISOFOL MEDICAL AB | Health Technology |